Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE)
Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of mesenchymal stem cells
(MSCs) obtained from umbilical cords for the treatment of adults with systemic lupus
erythematosus (SLE). The goal of this study is to determine if patients receiving an MSC
infusion plus standard of care respond better than patients receiving placebo infusion plus
standard of care.